Differential SHIP2 Activation by EGF and Insulin Uncovers Pathway-Specific Control of PI(3,4)P2 Signaling
Molecular Medicine Division
Dr. Várnai Péter
Salló Zoltán
2026-07-31
ENHANCING CLINICAL OUTCOMES IN ATRIAL FIBRILLATION ABLATION: EVALUATION OF HIGH- AND VERY HIGH-POWER SHORT-DURATION TECHNIQUES AND THE ROLE OF LOCAL IMPEDANCE DROP IN GUIDING EFFECTIVE PULMONARY VEIN ISOLATION
Cardiovascular Medicine and Research Division
Dr. Szegedi Nándor
Biczók Zsuzsanna
2026-07-29
Investigation of the effects of altered and split pegRNAs on intramolecular complementarity and prime editing outcomes
Molecular Medicine Division
Dr. Welker Ervin
Nagy Bettina
2026-07-29
An Integrated Approach to Critically Ill Cardiac Patients: Environmental Risk Factors, Prognostication, and Long-Term Outcomes with Device-Based Follow-Up
Cardiovascular Medicine and Research Division
Dr. Zima Endre István
Arezoo Haghighi
2026-07-16
Identifying Novel Therapeutic Strategies Targeting Toll-Like Receptors for NSAID-Induced Enteropathy
Gyógyszertudományok és Egészségügyi Technológiák Tagozat
Dr. Zádori Zoltán
Gém Janka Borbála
2026-07-09
Investigation of Angiotensin II-induced Gene Expression Changes in Vascular Smooth Muscle Cells
Molecular Medicine Division
Dr. Balla András és Dr. Hunyady László
Lengyel Lívia
2026-07-08
Mental Health Sciences Division
Dr. Lám Judit
Derek Norman
2026-07-02
Development and mechanistic evaluation of an extended-release LPAR2 agonist as a radiation medical countermeasure
Theoretical and Translational Medicine Division
Dr. Tigyi Gábor
László János Marcell
2026-06-30
NEUROPROTECTIVE AND BLOOD–BRAIN BARRIER–STABILIZING EFFECTS OF N,N-DIMETHYLTRYPTAMINE UNDER ISCHEMIA–REPERFUSION CONDITIONS
János Szentágothai Neurosciences Division
Dr. Nardai Sándor Dr. Nagy Zoltán
Samaneh Haghighi
2026-06-26
MOLECULAR BACKGROUND OF NSAID INDUCED RENAL AND INTESTINAL DAMAGE
